THE CERVICAL CANCER PREVENTION SYSTEM IN RUSSIA:ARE GREAT CHANGES COMING?
Abstract
The purpose of this article is to review the state and prospects of the cervical cancer prevention in the Russian Federation. The provision of wide involvement of the risk population, appropriate screening regularity and high level of the lab-process quality is still cannot be achieved. The development of a brand-new surface plasmon resonance-based test for papillomavirus offers possibility to create an efficient and cost-effective system of the cervical cancer prevention.
About the Authors
I. E. Fadeev
Russian Medical Academy of Postgraduate Education of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
S. I. Rogovskaya
Russian Medical Academy of Postgraduate Education of the Ministry of Healthcare of the Russian Federation; National Medical Research Centre for Rehabilitation and Balneology
Russian Federation
Russian Federation
T. N. Poletova
Russian Medical Academy of Postgraduate Education of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
E. E. Mass
I. M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
References
1. Злокачественные новообразования в России в 2015 году: заболеваемость и смертность ; под ред. А. Д. Каприна, В. В. Старинского, Г. В. Петровой. М. : МНИОИ им. П. А. Герцена, 2017. 250 с.
2. Аксель Е. М. Статистика злокачественных новообразований женской половой сферы // Онкогинекология. 2012. № 1. С. 18-23.
3. Шакиров К. Т., Хасанов Р. Ш., Габитова С. Е., Раббаниев И. Ф., Нагуманов Э. В., Карпенко Л. Г. Организация скрининга рака шейки матки в Республике Татарстан // Поволж. онколог. вестн. 2012. № 4. URL: http://oncovestnik.ru/.
4. Аксель Е. М. Заболеваемость и смертность от злокачественных новообразований органов женской репродуктивной системы в России // Онкогинекология. 2015. № 1. C. 6-15.
5. Comprehensive cervical cancer control: A guide to essential practice ; 2-nd edition. Geneva, Switzerland : World Health Organization, 2014. 408 p.
6. Sankaranarayanan R., Wesley R. А practical manual оn visual screening for cervical neoplasia. IARC Technical Publication No. 41. Lyon, France : IARC Press, 2003. 59 p.
7. Gaffik in L., Blumenthal P. D., Emerson M., Limpaphayom K. Safety, acceptability, and feasibility of а single -visit approach to cer vical-cancer prevention in rurаl Thailand: а demonstration project : Royal Thai College of Obstetricians and Gynaecologists (RTCOG)/JHPIEGO Corporation Cervical Саnсer Prevention Group // Lancet. 2003. Vol.61. P. 814-820.
8. Denny L., Kuhn L., De Souza М., Pollack А., Dupree W., Wright Т. С. Jr. Screen-and-treat approaches for cervical саnсеr prevention in low-resource settings: а randomized соntrolled trial // JAМA. 2005. Vol. 294. P. 2173-2181.
9. Но G. Y., Bierman R., Beaqrdsley L., Chang C. J., Burk R. D. Natural history of cervicovaginal papillomavirus infection in young women // N Engl J Med. 1998. Vol.338. P. 423-428.
10. Wheeler С. М., Greer С. Е., Becker Т. М., Hunt W. C., Anderson S. М., Manos М. М. Short-term fluctuations in the detection of cervical human papillomavirus DNA // Obstet Gynecol. 1996. Vol. 88. P. 261-268.
11. Hildesheim A., Schiffman M. H., Gravitt P. E., Glass A. G., Greer C. E., Zhang T. et al. Persistence of type- specific human papillomavirus infection among cytologically normal women //J Infect Dis. 1994. Vol.169. P. 235-240.
12. Evander М., Edlund К., Gustafsson А., Jonsson М., Karlsson R., Rylander Е. et al. Human papillomavirus infection is transient in young women: а population- based cohort study // J Infect Dis. 1995. Vol. 171. P. 1026-1030. Обзор литературы ПРОФИЛАКТИЧЕСКАЯ МЕДИЦИНА
13. Moscicki А. В., Palefsky J. M., Smith G., Siboshski S., Schoolnik G. Variability of human papillomavirus DNA testing in а longitudinal cohort of young women // Obstet Gynecol. 1993. Vol. 82. P. 578-585.
14. Koutsky L. A., Holmes K. K., Critchlow C. W. et al. А cohort study of the risk of cervical intraepithelial neoplasia grade 2 оr 3 in relation to papillomavirus infection // N Engl J Med. 1992. Vol. 327 (18). P. 1272- 1278.
15. Wright Т. С. Jr., Оеnnу L., Kuhn L., Pollack А., Lorincz А. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical саnсеr // JAМA. 2000. Vol. 283. P. 81-86.
16. Belinson J. L., Qiao Y. L., Pretorius R. G., Zhang W. H., Rong S. О., Huang M. N., et al. Province cervical саnсеr screening study II: self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology // Int J Gynecol Саnсеr. 2003. Vol. 13. P. 819-826.
17. Wright Т. С. Jr., Сох J. Т., Massad L., Twiggs L. B., Wilkinson E. J. Consensus guidelines for the management of women with cervical cytological abnormalities : ASCCP-Sponsored Consensus Conference // JAMA. 2002. Vol. 287. P. 2120-2129.
18. Gravitt Р. Е., Burk R. D., Lorincz А., Неrrеrо R. F., Hildesheim А., Sherman М. Е. et al. А comparison between Real-Time Polymerase and Hybrid Capture 2 for human papillomavirus DNA quantitation // Саnсеr Epidemiol Biom Рrеv. 2003. Vol. 12. P. 477-484.
19. Schlecht N., Trevisan А., Duarte-Franco Е., Rohan Т. Е., Ferenczy А., Villa L. L., et al. Viral load as а predictor of the risk of cervical intraepithelial neoplasia // Int J Саnсеr. 2003. Vol. 103. P. 519-524.
20. Vаn Duin М., Snijders Р. J., Schrijnemakers H. F., Voorhorst F. J., Rozendaal L., Nobbenhuis М. А. et al. Human papillomavirus 16 load in normal and abnormal cervical scrapes: аn indicator of CIN II/ III and viral clearance // Int J Саnсеr. 2002. Vol. 98. P. 590-595.
21. He X., Yang P., Wang H., Wang Y., Liu S. Human Papillomavirus Genotyping by Surface Plasmon Resonance-Based Test // Clin Lab. 2016. Vol. 62 (11). P. 2079-2084.
22. Jeronimo J. et al. Secondary Prevention of Cervical Cancer : ASCO Resource-Stratified Clinical Practice Guideline. Published online 12.10.2016. URL: http:// www.asco.org/rs-cervical-cancer-secondary-prev- guideline.
23. Cervical Cancer: Screening. Rockville. MD: AHRQ.September 12, 2017. US Preventive Services Task Force Draft Recommendation Statement. URL: http://www.uspreventiveservicestaskforce.org/.
Review
For citations:
Fadeev I.E., Rogovskaya S.I., Poletova T.N., Mass E.E. THE CERVICAL CANCER PREVENTION SYSTEM IN RUSSIA:ARE GREAT CHANGES COMING? Vestnik SurGU. Meditsina. 2018;(3 (37)):41-45. (In Russ.)
Views:
238
Email this article 
